CLINICAL_TRIALS
trial_result
· 2010-10-22
Clinical Trial Update: Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia [Phase 3]
Summary
Phase 3 trial comparing olanzapine pamoate depot with oral olanzapine in outpatients with schizophrenia; results were posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-10-22